```html

Small Intestinal Bacterial Overgrowth (SIBO) – A Patient‑Focused Guide

Overview

Small intestinal bacterial overgrowth (SIBO) occurs when excessive numbers of bacteria colonize the small intestine, a region that normally contains relatively few microbes compared with the colon. The overgrowth interferes with digestion and absorption, leading to a spectrum of gastrointestinal (GI) and systemic symptoms.

Who it affects: SIBO can develop at any age but is most common in adults between 30‑70 years. Women appear to be slightly more affected than men, likely because many risk factors (e.g., irritable bowel syndrome, pelvic surgery) are more prevalent in females.

Prevalence: Population‑based studies estimate that SIBO is present in 6‑15 % of the general population. In specific groups, the rates soar—up to 40 % in patients with irritable bowel syndrome (IBS), 50 % in those with Crohn’s disease, and >70 % in individuals with chronic pancreatitis or prior intestinal surgery (Mayo Clinic; NIH).

Symptoms

SIBO produces a varied symptom profile because bacterial fermentation of food generates gases and metabolites that irritate the gut and damage the mucosa. Common symptoms include:

• Abdominal bloating – A sensation of fullness or swelling, often worse after meals.
• Excessive gas (flatulence) – Due to fermentation of carbohydrates into hydrogen, methane, or hydrogen sulfide.
• Diarrhea – Loose, watery stools; may be intermittent.
• Constipation – Some patients, especially those with methane‑producing bacteria, experience difficult, infrequent stools.
• abdominal cramping or pain – Usually related to gas distention.
• Fatigue or brain fog – May result from malabsorption of nutrients and systemic inflammation.
• Unintended weight loss – When malabsorption is severe.
• Nausea or early satiety – Feeling full after a small amount of food.
• Vitamin deficiencies – Particularly B12, iron, and fat‑soluble vitamins (A, D, E, K) due to impaired absorption.
• Joint or muscle aches – Less common, thought to be immune‑mediated.

Symptoms often worsen after meals rich in fermentable carbohydrates (e.g., beans, dairy, wheat, certain fruits). The pattern may fluctuate, with periods of remission and flare‑ups.

Causes and Risk Factors

SIBO is usually not caused by a single factor; rather, it arises when normal protective mechanisms of the small intestine break down.

Mechanisms that normally prevent overgrowth

• Intestinal motility – The migrating motor complex (MMC) sweeps residual food and bacteria downstream during fasting.
• Acidic gastric secretions – Low pH kills many ingested microbes.
• Intact ileocecal valve – Prevents colonic bacteria from refluxing upward.
• Immune surveillance – Secretory IgA and antimicrobial peptides keep bacterial numbers low.

Key risk factors

• Motility disorders – Diabetes‑related gastroparesis, scleroderma, hypothyroidism, or medications that slow gut transit (opioids, anticholinergics).
• Structural abnormalities – Prior gastric bypass, small‑bowel resection, strictures, diverticula, or blind loops created by surgery.
• Low stomach acid – Chronic use of proton‑pump inhibitors (PPIs) or H2 blockers.
• Immune deficiency – HIV/AIDS, common variable immunodeficiency, or immunosuppressive therapy.
• Chronic pancreatitis or celiac disease – Both impair digestion and alter the luminal environment.
• IBS and functional GI disorders – Up to 50 % of IBS patients test positive for SIBO.
• Age – People over 65 have slower MMC activity and are at higher risk.

Diagnosis

Diagnosing SIBO can be challenging because symptoms overlap with many other GI conditions. A systematic approach combines clinical assessment with objective testing.

Breath tests

The most widely used, non‑invasive tools are hydrogen and methane breath tests.

• Glucose Breath Test (GBT) – Patient drinks a 75 g glucose solution; breath samples are collected every 15–20 minutes for 2 hours. A rise >20 ppm hydrogen or >10 ppm methane above baseline suggests SIBO.
• Lactulose Breath Test (LBT) – Uses lactulose (a non‑absorbable sugar). A rapid early peak in hydrogen/methane (within 90 minutes) indicates overgrowth in the proximal small bowel.

Both tests have sensitivities of 60‑80 % and specificities of 70‑85 % (American College of Gastroenterology guidelines). False positives can occur with rapid transit or recent antibiotic use, so patients should stop antibiotics, probiotics, and laxatives for at least 2 weeks before testing.

Direct aspiration and culture

During an upper endoscopy, fluid can be aspirated from the jejunum and cultured. A count >10⁵ colony‑forming units (CFU)/mL is the classic diagnostic threshold. This method is definitive but invasive, costly, and not routinely performed.

Additional work‑up

• Complete blood count and iron studies – to detect anemia.
• Serum vitamin B12, folate, and fat‑soluble vitamins – assess malabsorption.
• Stool studies – rule out concurrent infections (e.g., Giardia).
• Imaging (CT, MRI, or small‑bowel follow‑through) – evaluates structural causes.

Treatment Options

Therapy targets three goals: eradicate excess bacteria, restore normal motility, and correct nutritional deficiencies.

Antibiotic regimens

Antibiotics are first‑line. Choice depends on the dominant gas measured in breath testing.

• Rifaximin 550 mg three times daily for 14 days – effective for hydrogen‑dominant SIBO; cure rates 70‑80 % (Mayo Clinic). Minimal systemic absorption.
• Neomycin 500 mg twice daily for 7‑10 days – added when methane is present (methane‑producing archaea). Combination (rifaximin + neomycin) improves response in 85 % of mixed cases.
• Metronidazole or Ciprofloxacin – alternatives when rifaximin unavailable, though higher side‑effect profiles.

Recurrence is common (30‑50 % within 6 months); repeat testing after therapy helps guide retreatment.

Prokinetic agents

Restoring the MMC reduces bacterial stasis.

• Prucalopride 2 mg daily or Erythromycin low‑dose (250 mg QID) for short courses.
• Low‑dose naltrexone and 5‑HT4 agonists (e.g., tegaserod) are emerging options.

Dietary modifications

While diet alone rarely cures SIBO, it can lessen symptoms and support eradication.

• Low‑FODMAP diet – reduces fermentable substrates; typically 4‑6 weeks.
• Specific Carbohydrate Diet (SCD) or Elemental diet – for refractory cases, an elemental formula (e.g., Peptamen) provides nutrition without fermentable carbs and can be used for 2‑3 weeks.
• Slowly re‑introduce carbohydrate varieties after antibiotics to gauge tolerance.

Probiotics and prebiotics

Evidence is mixed. Some studies show that Lactobacillus plantarum or Bifidobacterium infantis may reduce bloating, but high‑dose probiotics can worsen gas in some patients. Use only under clinician guidance.

Addressing nutritional deficiencies

Supplement vitamin B12 (intramuscular or high‑dose oral), iron, and fat‑soluble vitamins as needed. A registered dietitian can tailor a replacement plan.

Management of underlying conditions

Control diabetes, adjust PPIs, treat hypothyroidism, or surgically correct strictures or blind loops. Without addressing the root cause, recurrence is likely.

Living with Small Intestinal Bacterial Overgrowth (SIBO)

Successful long‑term management combines medical therapy with daily habits that keep bacterial counts in check.

Practical tips

• Meal timing – Eat three moderate meals per day and avoid snacking between meals; this allows the MMC to “clean” the small intestine.
• Chew thoroughly – Improves digestion and reduces large carbohydrate particles that feed bacteria.
• Hydration – Aim for 1.5–2 L of water daily, but avoid sugary drinks that can ferment.
• Mindful carb intake – Limit high‑FODMAP foods (e.g., onions, garlic, apples, honey) especially during flare‑ups.
• Regular physical activity – Light to moderate exercise (walking, yoga) promotes gut motility.
• Stress management – Chronic stress impairs the MMC; consider meditation, deep‑breathing, or counseling.
• Medication review – Discuss with your doctor if you’re on long‑term PPIs or opioids; alternatives may reduce SIBO risk.
• Follow‑up testing – Repeat breath test 2–4 weeks after completing antibiotics to confirm eradication.

When to call your provider

• Worsening diarrhea, severe abdominal pain, or blood in stool.
• Signs of malnutrition (unintentional weight loss >10 % body weight, persistent fatigue).
• Recurrent symptoms after a completed treatment course.

Prevention

While not all cases are avoidable, several strategies can lower the likelihood of developing SIBO:

• Maintain optimal gut motility – Manage diabetes, thyroid disease, and avoid chronic opioid use.
• Use acid‑suppressing drugs sparingly – Reserve PPIs for proven indications and use the lowest effective dose.
• Adopt a balanced diet – Include fiber‑rich, low‑FODMAP vegetables, moderate protein, and limit excess simple sugars.
• Stay up to date with vaccinations – Prevent infections (e.g., influenza) that can disrupt the gut flora.
• Promptly treat intestinal infections – Early eradication of parasites or bacterial gastroenteritis reduces the chance of bacterial overgrowth.
• Regular follow‑up after abdominal surgery – Imaging or motility studies can catch anatomical issues early.

Complications

If left untreated, SIBO may lead to:

• Malabsorption syndromes – Chronic diarrhea, steatorrhea, and deficiencies in vitamin B12, iron, calcium, and fat‑soluble vitamins.
• Weight loss and muscle wasting – Due to nutrient loss.
• Osteoporosis – Secondary to calcium and vitamin D malabsorption.
• Peripheral neuropathy – Linked to B12 deficiency.
• Worsening of IBS or functional GI disorders – Persistent symptoms may impact quality of life.
• Small‑bowel mucosal injury – Bacterial metabolites (e.g., bile‑acid deconjugation) can damage the enterocyte surface.

When to Seek Emergency Care

---

**References** (accessed April 2026):

• Mayo Clinic. “Small intestinal bacterial overgrowth (SIBO).” https://www.mayoclinic.org
• National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). “SIBO – Overview.” https://www.niddk.nih.gov
• American College of Gastroenterology. “Guidelines for the Diagnosis and Management of SIBO.” Gastroenterology, 2023.
• Cleveland Clinic. “SIBO: Symptoms, Diagnosis, Treatment.” https://my.clevelandclinic.org
• World Health Organization. “Antimicrobial stewardship and gastrointestinal infections.” WHO publications, 2022.

```